This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Southern Research Institute, German University. Active years: 2015-2016.
Company Filing History:
2 out of 205 
1 out of 1 Years Active: 2015-2016
Title: Innovations of Ashraf H Abadi
Introduction
Ashraf H Abadi is a notable inventor based in Cairo, Egypt. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that offer therapeutic benefits with reduced toxicity.
Latest Patents
Abadi holds two patents that showcase his innovative work. The first patent is titled "Derivatives of celecoxib, use thereof and preparation thereof." This invention presents derivatives of celecoxib that lack cyclooxygenase inhibitory activity but possess improved PDE5 inhibitory activity. These compounds are designed for the treatment or prevention of cancer, chronic inflammatory conditions, erectile dysfunction, pulmonary hypertension, congestive heart failure, and enhancement of cognitive function. The second patent is "Tetrahydro-beta-carboline derivatives, synthesis and use thereof." This patent includes certain derivatives of tetrahydro-beta-carbolines that are useful for cancer prevention and treatment, as well as other conditions where PDE5 inhibitors have shown benefits.
Career Highlights
Throughout his career, Abadi has worked with reputable organizations such as Southern Research Institute and the German University. His work has focused on synthesizing compounds that can provide therapeutic benefits while minimizing side effects.
Collaborations
Abadi has collaborated with various professionals in his field, including Gary A Piazza, enhancing the scope and impact of his research.
Conclusion
Ashraf H Abadi's contributions to pharmaceutical innovations reflect his commitment to improving treatment options for various medical conditions. His patents demonstrate a blend of creativity and scientific rigor that continues to influence the field.